Pharma Journalist -

Shionogi asserted that the NDA for lusutrombopag (S-888711), an investigational, once-daily, orally administered , small molecule thrombopoietin (TPO) receptor agonist, has been…
Read More...

Pharmaceutical company, Neumentum committed to transforming the way acute and chronic pain are treated-without  opioids asserted the confirmation of Type B meeting with the U.S FDA…
Read More...

Therapy combinations, Biomarkers and the challenge of prayer coverage for CAR T-cell therapy are the topics selected for this year's special tissue on immuno-oncology in  Evidence-Based…
Read More...

EpimAb Biotherapeutics which is essentially a biologics company based in Shanghai, China emphasizing on developing a portfolio of bispecific antibodies declared the appointment of Bin…
Read More...

Genomic Health asserted the U.S commercial launch of  Oncotype DX AR-V7 Nucleus Detect test. The Oncotype DX AR-V7 Nucleus Detect test was developed by Epic Sciences to help prolong the…
Read More...

The Journal of the American Osteopathic Association signified inefficiency of Vitamin D that can't be metabolized owing to low Magnesium Levels that implies Vitamin D remains stored and…
Read More...

CE Mark approval was sought for EPD's Cardiac Mapping and Navigation System. The system helps electrophysiologists navigate the heart by generating a succinct 3D Map while imaging and…
Read More...

Leading Science and technology company, Merck announced that the Argentinian Administration of Medicines, Food and Medical Technology has sanctioned the registration of MAVENCLAD …
Read More...

The opioid crisis has cost the economy $1 trillion since 2001 in the USA alone, and the prospect does not look like it will get better any time soon. A recent study performed by Altarum…
Read More...

Atrium Health's Levine Children's Hospital proved to be a new trial site to test a new medicine for children that can regulate and stabilize their blood pressure in fatal circumstances.…
Read More...